Financial Data and Key Metrics Changes - Total assets increased by 20% to $1.1 billion compared to the end of 2021 [5] - Investment portfolio at cost grew by 45%, generating total investment income of $145.5 million [5] - Net investment income (NII) for Q4 was $21.6 million, representing a 104% increase year-over-year, and $71.6 million for the full year, an 83% increase [5][19] - The company declared combined regular and supplemental dividends totaling $2.33 per share for 2022, an 85% increase over 2021 [6] - Return on average equity based on NII increased to 17.9% [6] Business Line Data and Key Metrics Changes - Originated $976 million in new commitments and funded $631 million across 66 portfolio companies [7][8] - The portfolio grew to $1.1 billion on a fair value basis, a 25% increase [8] - The effective yield on the portfolio for Q4 was 15.5%, up from 15.2% in Q3 [17] - Core yield increased to 14.2% from 13.5% in the prior quarter [17] Market Data and Key Metrics Changes - The company ended Q4 with $393 million of unfunded commitments, providing a strong pipeline for future fundings [9] - Approximately 95% of the debt investments at cost were performing [21] - The average credit rating for the portfolio was 2.8, slightly lower than the previous quarter [21] Company Strategy and Development Direction - The company is focusing on cautious investment opportunities while navigating a volatile market [10] - Plans to expand the life sciences team and enhance the platform for future growth [8] - The joint venture and RIA structure are expected to provide additional fee income and off-balance sheet growth [10][22] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the potential for growth despite market challenges, emphasizing the importance of sound judgment in investment decisions [10] - The company is monitoring portfolio companies closely, maintaining communication to manage credit risk effectively [11][21] - Management noted that venture capital investors are still willing to support companies that are slightly underperforming, but valuations have decreased [34][36] Other Important Information - The company repurchased approximately 186,000 shares at an average price of $10.77 per share, demonstrating commitment to shareholder value [23] - NAV per share decreased to $13.15 from $13.74, primarily due to unrealized depreciation and realized losses [15] Q&A Session Summary Question: Can you provide insights on portfolio company liquidity and fundraising? - Management actively monitors portfolio liquidity on a company basis, focusing on ensuring 18 to 24 months of runway for new investments [25][26] Question: What is the target leverage level? - The target leverage range is 115% to 135%, with plans to maintain it at the upper end [29] Question: Any thoughts on equity raises given the stock price? - Management is cautious about equity raises but will consider them if stock price reacts positively [30] Question: When can we expect the first fund from the RIA to be operational? - The first fund is expected to be operational within the next six months, contributing to fee income [33] Question: What is the current trend in loan spreads? - The company continues to push on pricing, with spreads trending upwards [41] Question: What are the expectations for M&A activity? - Increased M&A activity is anticipated, particularly in private equity, while traditional exit markets may be less active [44]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-39958 TRINITY CAPITAL INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Mar ...

Trinity Capital Inc. (NASDAQ:TRIN) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Sarah Stanton - General Counsel Steven Brown - Chairman and Chief Executive Officer David Lund - Chief Financial Officer Michael Testa - Chief Accounting Officer Gerald Harder - Chief Operating Officer Ron Kundich - Chief Credit Officer Conference Call Participants Christopher Nolan - Ladenburg Thalmann Ryan Lynch - KBW Casey Alexander - Compass Point Bryce Rowe - B. Riley Jordan Wathen - Wel ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-39958 TRINITY CAPITAL INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organiza ...

Trinity Capital Inc. (NASDAQ:TRIN) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Sarah Stanton – General Counsel Steve Brown – Chairman and Chief Executive Officer Kyle Brown – President and Chief Investment Officer David Lund – Chief Financial Officer Michael Testa – Chief Accounting Officer Gerry Harder – Chief Operating Officer Conference Call Participants Finian O’Shea – Wells Fargo Ryan Lynch – KBW Christopher Nolan – Ladenburg Thalmann Paul Johnson – KBW Operator Good ...

Second Quarter 2022 Investor Presentation TRINITY C FUELING DISRUPTIVE TECHNOLOGIES. REVOLUTIONIZING THE FUTURE. FORWARD LOOKING STATEMENTS | DISCLAIMER Trinity Capital Inc. (the "Company") cautions that this presentation may contain forward-looking statements that are based on current expectations and assumptions about future events, and which are not based in historical fact. The forward-looking statements in this presentation are based on current conditions as of the date of this presentation, and includ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-39958 TRINITY CAPITAL INC. (Exact name of registrant as specified in its charter) Maryland 35-2670395 (State or other jurisdiction of incorporat ...

T R I N I T Y C A P I T A L A National Leader in Growth Stage Lending First Quarter 2022 Investor Presentation FORWARD LOOKING STATEMENTS | DISCLAIMER Trinity Capital Inc. (the "Company") cautions that this presentation may contain forward-looking statements that are based on current expectations and assumptions about future events, and which are not based in historical fact. The forward-looking statements in this presentation are based on current conditions as of the date of this presentation, and include, ...

Trinity Capital, Inc. (NASDAQ:TRIN) Q1 2022 Earnings Conference Call May 9, 2022 5:00 PM ET Company Participants Sarah Stanton - Chief Compliance Officer, General Counsel & Secretary Steven Brown - Chairman & CEO Kyle Brown - President, CIO & Director David Lund - CFO Michael Testa - CAO Gerald Harder - Chief Credit Officer Conference Call Participants Ryan Lynch - KBW Finian O'Shea - Wells Fargo Securities Christopher Nolan - Ladenburg Thalmann & Co. Casey Alexander - Compass Point Research & Trading Opera ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-39958 TRINITY CAPITAL INC. (Exact name of registrant as specified in its charter) Maryland 35-2670395 (State or other jurisdiction of incorpora ...